These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 18341379)

  • 21. [Novel treatment opportunities in Graves' orbitopathy].
    Erdei A; Gazdag A; Bodor M; Berta E; Katkó M; Ujhelyi B; Steiber Z; Győry F; Urbancsek H; Barna S; Galuska L; Nagy VE
    Orv Hetil; 2014 Aug; 155(33):1295-300. PubMed ID: 25109914
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The expected and unexpected: key points in the 2021 European Group on Graves' Orbitopathy clinical practice guidelines for the management of Graves' orbitopathy].
    Pan Q; Lyu ZH; Guan HX
    Zhonghua Nei Ke Za Zhi; 2022 Jan; 61(1):8-11. PubMed ID: 34979768
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Asymmetry indicates more severe and active disease in Graves' orbitopathy: results from a prospective cross-sectional multicentre study.
    Perros P; Žarković MP; Panagiotou GC; Azzolini C; Ayvaz G; Baldeschi L; Bartalena L; Boschi AM; Nardi M; Brix TH; Covelli D; Daumerie C; Eckstein AK; Fichter N; Ćirić S; Hegedüs L; Kahaly GJ; Konuk O; Lareida JJ; Okosieme OE; Leo M; Mathiopoulou L; Clarke L; Menconi F; Morris DS; Orgiazzi J; Pitz S; Salvi M; Muller I; Knežević M; Wiersinga WM; Currò N; Dayan CM; Marcocci C; Marinò M; Möller L; Pearce SH; Törüner F; Bernard M;
    J Endocrinol Invest; 2020 Dec; 43(12):1717-1722. PubMed ID: 32474767
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current and Emerging Treatment Strategies for Graves' Orbitopathy.
    Genere N; Stan MN
    Drugs; 2019 Feb; 79(2):109-124. PubMed ID: 30659423
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management of Graves' hyperthyroidism and orbitopathy in time of COVID-19 pandemic.
    Bartalena L; Chiovato L; Marcocci C; Vitti P; Piantanida E; Tanda ML
    J Endocrinol Invest; 2020 Aug; 43(8):1149-1151. PubMed ID: 32441005
    [No Abstract]   [Full Text] [Related]  

  • 26. Treatment of moderate to severe orbitopathy: Current modalities and perspectives.
    Bouzehouane N; Borson-Chazot F; Abeillon J; Caron P
    Ann Endocrinol (Paris); 2021 Apr; 82(2):92-98. PubMed ID: 33676921
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Diagnosis and treatment of dysthyroid orbitopathy: a multidisciplinary disease].
    Leray B; Imbert P; Thouvenin D; Boutault F; Caron P
    J Fr Ophtalmol; 2013 Dec; 36(10):874-85. PubMed ID: 24239215
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Graves' orbitopathy: diagnosis, epidemiology and treatments].
    Lun AY; Le Bras M; Scharbarg E; Morcel P; Hadjadj S; Lebranchu P; Drui D
    Rev Med Interne; 2022 Apr; 43(4):242-251. PubMed ID: 35221112
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Amsterdam Declaration on Graves' orbitopathy.
    Perros P; Wiersinga WM
    Thyroid; 2010 Mar; 20(3):245-6. PubMed ID: 20187780
    [No Abstract]   [Full Text] [Related]  

  • 30. A questionnaire survey on the management of Graves' orbitopathy in Europe.
    ; Perros P; Baldeschi L; Boboridis K; Dickinson AJ; Hullo A; Kahaly GJ; Kendall-Taylor P; Krassas GE; Lane CM; Lazarus JH; Marcocci C; Marino M; Mourits MP; Nardi M; Orgiazzi J; Pinchera A; Pitz S; Prummel MF; Wiersinga WM
    Eur J Endocrinol; 2006 Aug; 155(2):207-11. PubMed ID: 16868132
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence and natural history of Graves' orbitopathy in a large series of patients with newly diagnosed graves' hyperthyroidism seen at a single center.
    Tanda ML; Piantanida E; Liparulo L; Veronesi G; Lai A; Sassi L; Pariani N; Gallo D; Azzolini C; Ferrario M; Bartalena L
    J Clin Endocrinol Metab; 2013 Apr; 98(4):1443-9. PubMed ID: 23408569
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Editorial: News in Graves' orbitopathy: patients management and treatments.
    Lanzolla G; Sabini E
    Front Endocrinol (Lausanne); 2023; 14():1270467. PubMed ID: 37664861
    [No Abstract]   [Full Text] [Related]  

  • 33. [Graves' orbitopathy].
    Balázs C
    Orv Hetil; 2006 Jun; 147(22):1011-7. PubMed ID: 16913090
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pediatric thyroid-associated orbitopathy: the Children's Hospital of Philadelphia experience and literature review.
    Goldstein SM; Katowitz WR; Moshang T; Katowitz JA
    Thyroid; 2008 Sep; 18(9):997-9. PubMed ID: 18713025
    [TBL] [Abstract][Full Text] [Related]  

  • 35. GO-QOL--disease-specific quality of life questionnaire in Graves' orbitopathy.
    Sawicka-Gutaj N; Bednarczuk T; Daroszewski J; Waligórska-Stachura J; Miśkiewicz P; Sowiński J; Bolanowski M; Ruchała M
    Endokrynol Pol; 2015; 66(4):362-6. PubMed ID: 26323474
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management of patients with Graves' orbitopathy: initial assessment, management outside specialized centres and referral pathways.
    Orgiazzi J
    Clin Endocrinol (Oxf); 2016 May; 84(5):662-3. PubMed ID: 26866718
    [No Abstract]   [Full Text] [Related]  

  • 37. Recent advances in the management of thyroid associated orbitopathy: A promising roadmap.
    Kurian DE; Kalra S; Kapoor N
    J Pak Med Assoc; 2022 Mar; 72(3):567-571. PubMed ID: 35320248
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Management of patients with Graves' orbitopathy: initial assessment, management outside specialised centres and referral pathways.
    Perros P; Dayan CM; Dickinson AJ; Ezra D; Estcourt S; Foley P; Hickey J; Lazarus JH; MacEwen CJ; McLaren J; Rose GE; Uddin J; Vaidya B
    Clin Med (Lond); 2015 Apr; 15(2):173-8. PubMed ID: 25824071
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum selenium status in Graves' disease with and without orbitopathy: a case-control study.
    Khong JJ; Goldstein RF; Sanders KM; Schneider H; Pope J; Burdon KP; Craig JE; Ebeling PR
    Clin Endocrinol (Oxf); 2014 Jun; 80(6):905-10. PubMed ID: 24372054
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Trends in Graves' orbitopathy research in the past two decades: a bibliometric analysis.
    Elubous KA; Alebous AD; Abous HA; Elubous RA; Alebous LA; Alshammari TO
    Arq Bras Oftalmol; 2022; 85(6):590-598. PubMed ID: 35170638
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.